(Q33757638)

29 July 2017

1 reference

title

Issues in the management of nasopharyngeal carcinoma (English)

1 reference

29 July 2017

Liu T

1

1 reference

29 July 2017

publication date

1 June 1999

1 reference

Critical Reviews in Oncology Hematology

29 July 2017

published in

1 reference

29 July 2017

volume

31

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

55-69

1 reference

On the epidemiology of nasopharyngeal carcinoma

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Trends in the clinical management of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

The efficacy of fiberoptic endoscopic examination and biopsy in the detection of early nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Clinical implications of the serum level of CD23 in patients with undifferentiated nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Skull base erosion in nasopharyngeal carcinoma: detection by CT and MRI

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Retropharyngeal lymphadenopathy in patients with nasopharyngeal carcinoma: a computed tomography-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Carcinoma of the nasopharynx: factors affecting prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Potential clinical efficacy of intensity-modulated conformal therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Three-dimensional treatment planning and conformal radiation therapy: preliminary evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Three-dimensional photon treatment planning for carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

1 reference

7 January 2021

Non-standard fractionation in radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Cell Kinetics, Models, and Cancer Treatment—Some Principles for the Radiation Oncologist

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

The histological structure of some human lung cancers and the possible implications for radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

The Phenomenon of Reoxygenation and Its Implications for Fractionated Radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Vascularization and curability of stage III and IV nasopharyngeal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Radiation response of mammalian cells grown in culture. 1. Repair of X-ray damage in surviving Chinese hamster cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Changes of cell proliferation characteristics in a rat rhabdomyosarcoma before and after X-irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Does the interval between fractions matter in the range of 4–8 h in radiotherapy? A study of acute and late human skin reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Staging of nasopharyngeal carcinoma: evaluation of N-staging by Ho and UICC/AJCC systems. Union Internationale Contre le Cancer. American Joint Committee for Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techniques and results

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Radiation Therapy of Nasopharyngeal Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

High Complete Response in Advanced Nasopharyngeal Carcinoma With Bleomycin, Epirubicin, and Cisplatin Before Radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Platinum-Based Chemotherapy Followed by Radiation Therapy of Locally Advanced Nasopharyngeal Cancer a Retrospective Analysis of 39 Cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a high rate of tumor response to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Pilot study of concurrent chemotherapy and radiotherapy for stage IV nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Preliminary report of outpatient weekly adjuvant chemotherapy for high-risk nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Radiation Therapy of Recurrent Nasopharyngeal Carcinoma: Report on 219 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Re-irradiation of recurrent nasopharyngeal carcinoma--treatment techniques and results

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Transcervico-mandibulo-palatal approach for surgical salvage of recurrent nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Maxillary swing approach for resection of tumors in and around the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: late complications following megavoltage irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Delayed radiation encephalopathy after radiotherapy for nasopharyngeal cancer: a CT study of 45 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

The effects of irradiation on the eye and optic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

Radiation retinopathy--clinical, histopathological, ultrastructural and experimental correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

MRI differentiation of recurrent nasopharyngeal carcinoma from postradiation fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

The role of MRI for the diagnosis of recurrence of nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900003-7

7 January 2021

10.1016/S1040-8428(99)00003-7

Identifiers

DOI

1 reference

29 July 2017

1 reference